Skip to main content
. 2013 Nov 11;8(11):e78856. doi: 10.1371/journal.pone.0078856

Figure 1. A Time course of serum Gamma-GT and AST levels; R Rituximab, A Adalimumab B Antibody titres of the study population.

Figure 1